
Anti Parasitic
ABD Plus
Albendazole & Ivermectin
400 MG & 12 MG · 1X1 Tablet
By INTAS
Pharmaceutical wholesale & export — request a bulk quote

Albendazole
ABD 400 MG tablet (albendazole) an oral anthelmintic for the treatment of various parasitic worm infections; supplied as 1x1 tablet, available without prescription.
In stock
ABD 400 MG contains albendazole, a broad‑spectrum anthelmintic indicated for the treatment of various parasitic worm infections. This product is formulated as an oral tablet for single‑unit dispensing. It is intended for use where albendazole therapy is appropriate according to local prescribing information and clinical judgement.
Albendazole is a benzimidazole class anti‑parasitic agent. Its primary pharmacological action is to bind to parasite beta‑tubulin, inhibiting microtubule polymerization. This disruption of microtubule function impairs glucose uptake and other essential cellular processes in susceptible parasites, leading to reduced motility and death of the organism. Albendazole has activity against a range of intestinal helminths and certain tissue parasites as stated in approved product labeling.
The product is supplied as a 400 mg tablet in a 1x1 tablet pack, suitable for sample dispensing, single‑unit distribution or inclusion in larger repackaging and distribution workflows. As a non‑prescription product in the provided listing, it may be distributed where allowed by local regulation; purchasers should verify local legal status and handling requirements prior to sale or import.
Typical therapeutic uses for albendazole include treatment of a spectrum of helminth infections as described in regulatory and clinical guidance. Specific indications, contraindications, precautions, interactions and safety information are set out in the official prescribing information. Dosing regimens and treatment duration should be determined by a qualified healthcare professional and by reference to local prescribing guidelines.
For wholesale, distribution or export enquiries about ABD 400 MG (albendazole) tablets, please contact our commercial team with required volume, destination country details, and regulatory documentation requests. Angel Pharma Export can provide packaging and product information to support importer due diligence and regulatory compliance, where applicable.
Albendazole is a broad-spectrum anthelmintic used for the treatment of various parasitic worm infections. Typical indications include intestinal helminthiases (such as ascariasis, trichuriasis, hookworm and enterobiasis) and tissue infections caused by cestodes (for example hydatid disease and neurocysticercosis). Use should follow local prescribing information and a qualified healthcare professional’s guidance.
Common adverse effects may include nausea, abdominal pain, headache and dizziness. Laboratory abnormalities such as transient elevations in liver enzymes and mild leukopenia can occur. Less common but serious reactions reported include significant hepatotoxicity, bone marrow suppression (including neutropenia) and hypersensitivity reactions. Patients should report unexplained fever, jaundice, severe fatigue or bleeding.
Key precautions and special population considerations: - Avoid use in pregnancy unless the potential benefit justifies the risk to the fetus; consult a specialist for pregnancy testing and counselling. - Monitor liver function tests and full blood counts during prolonged or repeated therapy. - Use caution and specialist advice in patients with known hepatic impairment or pre-existing blood dyscrasias. - Refer dosing and duration to the product label and a qualified healthcare professional.
Albendazole can cause hepatotoxicity and blood dyscrasias; baseline and periodic liver function tests and complete blood counts are recommended for prolonged or repeated courses. Avoid use in pregnancy unless the benefits outweigh risks. Use this medicine under the guidance of a qualified healthcare professional.
Clinically important interactions to consider: - Hepatic enzyme inducers (for example carbamazepine, phenytoin, rifampicin) may lower albendazole active metabolite levels and reduce efficacy. - Cimetidine can increase albendazole sulfoxide plasma concentrations. - Praziquantel may increase levels of albendazole sulfoxide. - Consider potential interactions with other hepatically metabolised or marrow-suppressing drugs and monitor accordingly.
Store in the original package, protected from moisture and light. Keep at room temperature per the pack label. Follow the product packaging for exact storage and expiry instructions.
Regulatory status varies by country. Although the product details list non-prescription status, local laws and import regulations may require a prescription. Purchasers and end-users should confirm national requirements and consult a qualified healthcare professional before use.
On request we can provide standard quality documentation commonly required for pharmaceutical imports, such as batch certificates, certificate of analysis (COA), and product specification documents. Specific documents provided will depend on regulatory and buyer requirements; contact our sales team to discuss needs.
Minimum order quantities depend on destination market, pack configuration and current stock. For clear confirmation of minimums and pricing, please contact our export sales team with your requested quantity, destination country and any regulatory requirements so we can provide a tailored response.
Maintain storage according to the product label: keep in original packaging, protected from moisture and excessive heat. During transit use standard pharmaceutical cold-chain or ambient handling as specified in the transport documentation. Confirm storage recommendations and shelf-life with our supply team before shipment.
Shipping pharmaceuticals is subject to national import regulations, licensing and documentation. Restrictions vary by country and product classification. Please provide destination details so our export compliance team can advise on required permits, invoices, certificates and any controlled-substance rules that might apply.
For prolonged or repeated treatment, clinical guidance recommends baseline and periodic liver function tests and full blood counts to detect hepatotoxicity or bone marrow suppression. Monitoring frequency should follow local prescribing information and the supervising healthcare professional’s judgement.
You may also need

Anti Parasitic
Albendazole & Ivermectin
400 MG & 12 MG · 1X1 Tablet
By INTAS

Anti Parasitic
Ivermectin
24 MG · 1X10 Tablet
By KachhelaMedexPvt.Ltd..
Anti Parasitic
ivermectin
40 MG · 1X10 Tablet
By KachhelaMedexPvt.Ltd..